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Treatment of homogeneous preparations of 2-amino- 
3-ketobutyrate CoA ligase from Escherichia coli, a pyr- 
idoxal 5’-phosphate-dependent enzyme, with phenyl- 
glyoxal, 4-(oxyacetyl)phenoxyacetic acid, 2,3-butane- 
dione, or 1,2-cyclohexanedione results in a time- and 
concentration-dependent loss of enzymatic activity. 
Phenylglyoxal in 50 mM phosphate buffer (pH 7.0) is the 
most effective modifier, causing >95% inactivation 
within 20 min at 25°C. Controls establish that this in- 
activation is not due to modifier-induced dissociation or 
photoinduced nonspecific alteration of the ligase. The 
substrate, acetyl CoA, or the coenzyme, pyridoxal 5’- 
phosphate, gives >50% protection against inactivation. 
Enzyme partially inactivated by phenylglyoxal has the 
same K, value for glycine but the V,,,,, decreases in pro- 
portion to the observed level of inactivation. Whereas 
the native apoligase shows good recovery of activity with 
time in parallel with an increase in 428-nm absorptivity 
when incubated with pyridoxal 5’-phosphate, no such ef- 
fects are seen with the phenylglyoxal-modified apoligase. 
Reaction of the enzyme with [‘4C]phenylglyoxal allowed 
for the isolation of a peptide which, by amino acid com- 
position and sequencing data, was found to correspond 
to residues 349-378 in the intact enzyme. These results 
indicate that arginine residue-366 and/or residue-368 
in the primary structure of E. coli 2-amino-3-ketobu- 
tyrate ligase is at the active site. @ 1992 Academic Press, Inc. 
Threonine metabolism in eukaryotes and prokaryotes 
has been known to occur via three pathways, one initiated 
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by threonine dehydratase, another by threonine aldolase, 
and a third by threonine dehydrogenase. Recent studies 
(l-3) have shown that the threonine dehydrogenase-ini- 
tiated route is probably the most important of the three; 
it accounts for 87% of the L-threonine degraded in the 
liver of normally fed rats (4), it is the only pathway for 
L-threonine degradation that is detected in chicken liver 
(5), and it assumes the predominant role in Escherichia 
coli (6) and other microorganisms (7). Threonine dehy- 
drogenase (EC 1.1.1.103) catalyzes the NAD+-dependent 
oxidation of L-threonine to 2-amino-3-ketobutyrate (or 
2-amino-3-oxobutanoate). 
2-Amino-3-oxobutanoate glycine-lyase (CoA-acetylat- 
ing) (EC 2.3.1.29), also called 2-amino-3-ketobutyrate li- 
gase, aminoacetone synthase, or aminoacetone synthe- 
tase, catalyzes the second step in the threonine 
dehydrogenase-initiated pathway; by this reaction, glycine 
and acetyl CoA are formed via a CoA-dependent cleavage 
of 2-amino-3-ketobutyrate. The conversion of threonine 
to glycine by the coupled action of these two enzymes 
accounts for the observation that glyA (serine hydroxy- 
methyltransferase gene) mutants can utilize threonine for 
growth (8-10). In cells that contain a functional glyA gene, 
these coupled reactions provide a highly efficient alternate 
route for serine biosynthesis (6). The genes for threonine 
dehydrogenase and 2-amino-3-ketobutyrate ligase make 
up the tdh operon which is located near minute 81 of the 
E. coli genetic map (11). The tdh operon is one among a 
multigene family that is regulated by L-leucine, medi- 
ated by the leucine-responsive regulatory protein (Lrp)4 
(12-14). 
In an earlier paper (15), we reported the purification 
of 2-amino-3-ketobutyrate ligase to homogeneity from 
extracts of a mutant of E. coli K-12 that we forced to grow 
4 Abbreviations used: Lrp, leucine-responsive regulatory protein; PTH, 
phenylthiohydantoin; PTC, phenylthiocarbamoyl; TFA, trifluoroacetic 
acid; SDS, sodium dodecyl sulfate. 
147 
148 MUKHERJEE AND DEKKER 
on L-threonine as sole carbon source; this mutant has 
constitutively derepressed levels of both threonine de- 
hydrogenase and the ligase. 2-Amino-3-ketobutyrate li- 
gase from E. coli is an 84,000-Da protein and consists of 
two apparently identical subunits. It is a pyridoxal 5- 
phosphate-dependent enzyme and is strictly specific for 
glycine. The primary structure of the kbl (2-amino-3-ke- 
tobutyrate CoA ligase) gene and that of its protein product 
are known (16). 
We are attempting to map active-site amino acid res- 
idues in both threonine dehydrogenase (17-19) and this 
ligase in efforts to elucidate how these two enzymes are 
tightly coupled or may even form a catalytic complex that 
allows for efficient passage of the unstable 2-amino-3- 
ketobutyrate to the ligase so that it is cleaved rather than 
spontaneously decarboxylated. In first studies with the 
E. coli ligase, we isolated and sequenced the active-site 
peptide containing the lysine residue that forms a Schiff 
base with pyridoxal5’-phosphate (20). We now report that 
an arginine residue (or residues), located in a peptide cor- 
responding to amino acid residues 349-378 in the native 
protein, is also a participant in the active site of this en- 
zyme. 
MATERIALS AND METHODS 
Enzymes and chemicals. Homogeneous samples of 2-amino-3-ke- 
tobutyrate ligase were prepared from extracts of mutant E. coli SBD- 
76 cells as reported earlier (15). The purity of all samples was established 
by polyacrylamide gel electrophoresis, both with and without SDS. The 
specific activity of enzyme preparations used in these studies was in the 
range of 2.5 to 2.8 units/mg of protein; a unit of ligase activity is defined 
as that amount which catalyzed the formation of 1 pmol of CoA/min 
at 25“C. Molar enzyme concentrations are based on the ligase being a 
homodimer with a relative molecular mass of 84 kDa (15). Staphylococcu.s 
aureus V8 endoproteinase was a product of Boehringer Mannheim Bio- 
chemicals. 
HPLC-grade methanol and acetonitrile were obtained from Burdick 
and Jackson Laboratories, Inc., whereas phenyl[2-i4C]glyoxal (27 mCi/ 
mmol) was from Research Products International Corp. The following 
materials were purchased from the companies noted: 5,5’-dithiobis(2. 
nitrobenzoic acid), phenylisothiocyanate, triethylamine, and PTH-amino 
acid standards from Pierce Chemical Co.; acetyl CoA and pyridoxal . HCl 
from Sigma Chemical Co.; phenylglyoxal, l$cyclohexanedione, and 2,3- 
butanedione from Aldrich Chemical Co.; pyridoxal 5’.phosphate from 
Nutritional Biochemicals Corp.; TFA from J. T. Baker Chemical Co. 
4-(0xyacetyl)phenoxyacetic acid was kindly provided by Drs. P. J. 
Duerksen-Hughs and K. D. Wilkinson of Emory University (Atlanta, 
GA). All other chemicals were of the highest purity commercially avail- 
able. 
The HPLC equipment used to obtain peptide maps and to separate 
PTH-amino acids has been described before (21). 
Assay of ligase actiuity and inactivation studies with dicarbonyl re- 
agents. 2.Amino+ketobutyrate ligase activity was measured spectro- 
photometrically at 412 nm as described earlier for Assay I (15). Unless 
indicated otherwise, inactivation studies were carried out by incubating 
the enzyme (12-15 pM) in the dark with a given dicarbonyl reagent in 
50 mM potassium phosphate buffer (pH 7.0) at 25°C. Aliquots (5-10 ~1) 
of the reaction mixture were removed at varying time intervals and 
mixed with 1 ml of the assay mixture, and the increase in absorbance 
at 412 nm was monitored. 
Protection of ligase actiuity against inactiuation byphenylglyoxal. An 
aliquot of the enzyme (12-15 PM) was first incubated for 30 min at 25°C 
alone or with acetyl CoA (2 mM), pyridoxal5’-phosphate (3 mM), glycine 
(100 and 200 mM), or L-threonine (10 and 50 mM) in 50 mM potassium 
phosphate buffer (pH 7.8). Phenylglyoxal (2 mM, final concentration) 
was then added to the incubation mixture and aliquots were subsequently 
removed at fixed time points over a period of 20 to 30 min for assay of 
ligase activity. Controls consisted of the enzyme alone or the enzyme 
plus acetyl COA, pyridoxal 5’-phosphate, glycine, or threonine in the 
absence of any phenylglyoxal. 
Coenzyme-dependent reactivation of natiue and phenylglyoxal-treated 
apoligase. Resolution of the holoenzyme was accomplished by dialyzing 
it against buffer containing 5 mM hydroxylamine as previously described 
(15). The apoligase (20 nmol) so prepared was first incubated for 50 min 
at 25°C in 50 mM potassium phosphate buffer (pH 7.0) either alone or 
with 10 mM phenylglyoxal. Pyridoxal 5’.phosphate (100 PM, final con- 
centration) was then added to the incubation mixtures and aliquots 
were subsequently removed at varying time intervals for measuring both 
ligase activity and absorptivity at 428 nm. 
Determination of the nature and number of essential amino acids mod- 
ified in the ligase. Two methods were used to confirm the usual reaction 
specifcity of phenylglyoxal with amino acid residues in proteins and to 
determine the number of residues modified; they were comparative amino 
acid analyses of the native and the phenylglyoxal-inactivated ligase and 
second, radioactive incorporation measurements with [‘4C]phenylglyoxal. 
For amino acid analyses, an aliquot of the enzyme (0.2 mg) was com- 
pletely inactivated by reaction with 10 mM phenylglyoxal for 40 min at 
25°C in 50 mM potassium phosphate buffer (pH 7.0). An aliquot (50 ~1) 
of this reaction mixture and a comparable amount of the native ligase 
treated in the same manner without phenylglyoxal were hydrolyzed for 
24 h at 110°C in 1 ml of 6 N HCl containing 20 ~1 of mercaptoacetic 
acid. 
For quantitative radioactive measurements, 2-amino-3-ketobutyrate 
ligase (10.5 nmol) was incubated at 25°C with 8 mM phenyl[2-i4C]glyoxal 
(sp act = 2175 dpm/nmol) in 50 mM potassium phosphate buffer (pH 
7.0); total volume = 0.8 ml. At specific times, aliquots (60 ~1) of the 
incubation mixture were removed and immediately mixed with 1 ml of 
ice-cold 10% trichloroacetic acid, and the mixtures were then centrifuged 
for 15 min at 5000 rpm. The precipitates were subsequently washed 
several times with ice-cold 10% trichloroacetic acid and finally briefly 
with cold ethanol before they were dried under vacuum. The solid residues 
remaining were dissolved in a small volume of 0.1 N NaCl and the levels 
of radioactivity in the resultant solutions determined by liquid scintil- 
lation counting techniques, making use of a Packard Model 3300 spec- 
trometer and Safety Solve scintillation mixture. 
Amino acid analyses. Prior to analysis, enzyme samples were dialyzed 
exhaustively against glass-redistilled water and then lyophilized. Anal- 
yses were usually performed on a Beckman Model 120C automatic amino 
acid analyzer equipped with a microbore column; half-cystine residues 
were determined as S-sulfocysteine after treating the acid hydrolysate 
with dithiothreitol and sodium tetrathionate (22). Tryptophan was 
measured by hydrolyzing the protein with 4 M methanesulfonic acid 
(23). On occasion, the amino acids present in protein hydrolysates were 
also determined by HPLC as PTC-amino acid derivatives using the 
Waters Pica-Tag system (24). 
Peptide isolation and sequencingprocedures. 2-Amino-3-ketobutyrate 
ligase (6 mg) from E. coli was incubated at 25°C with 10 mM phenyl[2- 
‘?]glyoxal (sp act = 1 &i/Kmol) in 50 mM potassium phosphate buffer 
(pH 7.0) for 30 min after which time less than 3% of the original ligase 
activity could be detected. The pH of the reaction mixture was then 
decreased to 4.0 by dropwise addition of 2 N HCl and the resulting 
solution dialyzed exhaustively against 50 mM sodium formate buffer 
(pH 4.0). The inactive enzyme adduct was subsequently digested with 
S. aureus V8 endoproteinase (25 to 1 mol ratio, enzyme to protease) at 
25°C for 24 h. The peptide solution so obtained was first passed through 
a Gelman Acre LC13 filter and aliquots of the filtrate were then injected 
directly onto a Waters Novapak C,s HPLC column (3.9 mm X 15 cm) 
at room temperature equilibrated with 0.1% (v/v) of TFA. Peptides 
were separated and eluted using TFA/acetonitrile solvent mixtures in 
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FIG. 1. (A) Effect of various dicarbonyl reagents on E. coli 2-amino- 
3-ketobutyrate ligase activity. The sample of enzyme used was first di- 
alyzed for 8 h at 4°C against 50 mM borate buffer (pH 7.8). The ligase 
(0.2 mg) was then incubated at 25°C with each reagent (10 mM) indicated 
in 50 mM borate buffer (pH 7.8); final volume, 0.2 ml. Aliquots (10 ~1) 
were removed at the times indicated, added to cuvettes in a final volume 
of 1.0 ml, and assayed as indicated in the text. OAPA, 4-(oxyace- 
tyl)phenoxyacetic acid. (B) Effect of buffer on ligase inactivation by 
phenylglyoxal. Enzyme as in (A) was incubated with 10 mM phenyl- 
glyoxal in 50 mM borate buffer (pH 7.8), 50 mM phosphate plus 50 mM 
borate buffer (pH 7.8), or 50 mM phosphate buffer (pH 7.8). Aliquots 
were removed and assayed as indicated for (A). Controls in (A) and (B) 
contained no dicarbonyl reagent. 
sequence as follows: O-25 min linear gradient (O-25%, v/v) of acetonitrile 
in O.l?C TFA; 25-75 min linear gradient (25555%) of acetonitrile in 
0.1% TFA. Fractions (1 ml) were collected and the presence of radio- 
activity therein was determined by liquid scintillation counting. 
Those fractions containing the radioactivity of interest were pooled 
and further purified by HPLC by passage through a Waters Novapak 
Cis analytical column using a linear gradient of 28-35% (v/v) acetonitrile 
in 0.1% TFA over a period of 60 min. The purified, radioactive peptide 
so obtained was concentrated to dryness and sequenced manually by 
the thin-film and the partitioning method described by Tarr (25). 
RESULTS 
Inactivation studies with various dicarbonyl re- 
agents. As is shown in Fig. lA, incubation of E. coli 2- 
amino-3-ketobutyrate ligase with 10 mM 1,2-cyclohex- 
anedione, 2$butanedione, 4-(oxyacetyl)phenyoxyacetic 
acid, or phenylglyoxal in 50 mM borate buffer (pH 7.8) 
results in a time-dependent loss of enzymatic activity. 
Phenylglyoxal was found to be the most effective of the 
modifiers tested, causing >95% inactivation within 20 
min. Figure 1B compares the rates of inactivation caused 
by 10 mM phenylglyoxal in borate as opposed to phosphate 
buffer; as can be seen, the rate is considerably faster and 
the extent greater in phosphate buffer. As a consequence, 
all subsequent inactivation studies were carried out with 
phenylglyoxal in phosphate buffer. 
Loss of 2-amino-3-ketobutyrate ligase activity is also 
dependent on the concentration of dicarbonyl reagent 
used; Fig. 2 shows a semilogarithmic plot of the rates of 
inactivation caused by varying concentrations of phenyl- 
glyoxal in 50 mM potassium phosphate buffer (pH 7.0). 
The rates were found not to be linear suggesting that 
more than one amino acid residue of different reactivity 
is quite likely being modified during the process of inac- 
tivation. The reaction order (n) with respect to the con- 
centration of phenylglyoxal was determined from the slope 
of a plot of log (lOOO/tl,J versus the log of reagent con- 
centration (mM). In this type of plot, a straight line was 
obtained giving a value of 1.30 + 0.10 (possible slopes 
within the error bars ranged from 0.74 to 1.88). 
With E. coli 2-amino-3-ketobutyrate ligase being a 
homodimeric protein (Xi), the possibility was considered 
that the loss of ligase activity on treatment with phenyl- 
gloxal might be due to dissociation of the enzyme into its 
subunits. To test this, a control sample of the enzyme 
and a sample inactivated 85% by reaction with phe- 
nylglyoxal were first dialyzed extensively against phos- 
phate buffer (50 mM, pH 7.0). These samples were then 
individually applied to and eluted from a column of Seph- 
adex G-100 that had been calibrated previously with pro- 
teins of known molecular weight. The two ligase samples 
were found to have identical elution profiles with the ex- 
pected relative levels of ligase activity and an elution vol- 
ume equal to that for a protein with M, E 84,000, dem- 
onstrating that phenylglyoxal inactivation is not a 
consequence of subunit dissociation. 
It has been reported (26-28) that certain dicarbonyl 
reagents used for selective modification of arginine resi- 
dues are photosensitive, causing a loss of enzymatic ac- 
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FIG. 2. Inactivation of E. coli 2-amino-3-ketobutyrate ligase by varying 
concentrations of phenylglyoxal. The enzyme (0.2 mg) was incubated 
in 50 mM potassium phosphate buffer (pH 7.0) at 25°C with the con- 
centrations of phenylglyoxal listed. At the time points plotted, a 10.~1 
aliquot was removed, added to cuvettes in a final volume of 1.0 ml, and 
assayed as indicated in the text. 
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tivity because of light-induced alterations in protein 
structure rather than chemical reaction with an essential 
residue. This possibility was avoided in the results pre- 
sented here by routinely carrying out the inactivation re- 
action in vessels protected from light. 
Protective effect of substrates, substrate analogs, or co- 
enzyme against inactivation. The effect that compounds 
added to the reaction mixture might have on the extent 
of inactivation caused by phenylglyoxal was tested. It was 
found that the presence of either acetyl CoA (2 mM) or 
pyridoxal 5’-phosphate (3 mM) gives >50% protection. 
When preincubated with the ligase, glycine also provides 
some protection against inactivation (-40 to 60%) but 
only when present at high concentrations (100 and 200 
mM, respectively). Since the unstable 2-amino-3-keto- 
butyrate per se is not available for use, threonine was 
tested as an analog; whereas 10 and 50 mM L-threonine 
showed good protection (-50 and 75%, respectively) no 
significant effect was seen when the same concentrations 
of D-threonine were tested. 
Kinetic values of partially inactivated ligase. The en- 
zyme used in these studies was treated with phenylglyoxal 
in the usual manner except that a limited extent of in- 
activation was accomplished by adding a threefold excess 
of L-arginine (relative to the initial concentration of 
phenylglyoxal) to the reaction mixture after a fixed in- 
terval of time. Thereafter, the mixture was dialyzed 
against 50 mM phosphate buffer (pH 7.0) to remove excess 
reagents and dialyzable reaction products. Reaction rates 
were measured using a constant level of acetyl CoA and 
varying concentrations of glycine; K,,, and V,,,,, values 
were calculated from the experimental data by Line- 
weaver-Burk plots (29) using a computer-assisted linear 
least-squares fit. Under the experimental conditions used, 
native enzyme was determined to have a K,,, = 12 mM for 
glycine and a V,,, = 2.90 pmol of CoA formed mini rng- ‘, 
whereas the corresponding values found for inactivated 
enzyme retaining 58% of the original level of activity were 
13 mM and 1.68 prnol mini’ rng-‘, respectively. 
Reactivation of native and phenylglyoxal-inactivated 
apoligase by pyridoxal 5’-phosphate. Previous studies 
showed that the enzymatic activity of the apoenzyme form 
of E. coli 2-amino-3-ketobutyrate ligase could be fully re- 
covered by incubation with pyridoxal 5’-phosphate but 
not by pyridoxal or pyridoxamine 5’-phosphate (15). Since 
pyridoxal 5’-phosphate gave protection against inactiva- 
tion of the native ligase by phenylglyoxal, we examined 
factors affecting reactivation of the apoligase. Under the 
experimental conditions reported here, good recovery of 
ligase activity with time in parallel with an increase in 
428-nm absorptivity was seen when the native apoenzyme 
was incubated with pyridoxal 5’-phosphate (Fig. 3). In 
contrast, when the apoligase was first modified by reaction 
with 10 mM phenylglyoxal under the usual conditions and 
then incubated with 100 pM pyridoxal 5’-phosphate for 
;-O 
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FIG. 3. Time-dependent regeneration of 2-amino+ketobutyrate li- 
gase activity and 428.run absorptivity of native and phenylglyoxal-mod- 
ified apoenzyme on incubation with pyridoxal Sphosphate. Apoligase 
preparation, its treatment with phenylglyoxal, and subsequent incubation 
with pyridoxal 5’-phosphate are described under Materials and Methods. 
Aliquots (10 ~1) of the reaction mixture were removed at the times in- 
dicated and assayed for both ligase activity (B) and absorptivity at 428 
nm (0). Controls contained apoligase not reacted with phenylglyoxal 
but incubated with either pyridoxal5’-phosphate (0 and 0, ligase activity 
and 428.nm absorptivity, respectively) or pyridoxal (A and a, activity 
and absorptivity, respectively). The absorbance and specific activity of 
the holoenzyme were taken as 100%. 
30 min, no recovery of enzymatic activity and only a slight 
increase in absorptivity at 428 nm was seen. Likewise, 
incubation of the native apoligase with pyridoxal caused 
no return of either catalytic activity or unique absorp- 
tivity. 
In this context, it was also considered whether the ob- 
served loss of some or all of the ligase activity on treatment 
with phenylglyoxal might possibly be due to dissociation 
of the holoenzyme. To test this, the levels of activity ex- 
hibited by pure holoenzyme and the holoenzyme inacti- 
vated 70% by phenylglyoxal were determined after they 
were first dialyzed against phosphate buffer and then 
preincubated (30 min at 4°C) with varying concentrations 
(0 to 100 pM) of pyridoxal 5’-phosphate. The added co- 
enzyme had no effect whatever on the level of activity of 
either enzyme sample, indicating that phenylglyoxal in- 
activation is not due to holoenzyme dissociation. 
Nature and number of essential amino acids modified 
in the inactivated ligase. Previous studies (30) showed 
that phenylglyoxal interacts specifically with the guani- 
dinium group of arginine in a stoichiometric relationship 
of 2 mol of reagent/m01 of arginine. To confirm this spec- 
ificity of reaction with E. coli 2-amino-3-ketobutyrate li- 
gase and to determine the number of residues modified, 
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amino acid analyses were carried out on native as well as 
dione-inactivated ligase. The amino acid composition de- 
termined for the native enzyme, showing 26.3 arginine 
residues per subunit, was in excellent agreement for each 
residue with that reported earlier (15). In contrast, 
whereas the content of all of the other amino acid residues 
was the same for the phenylglyoxal-inactivated enzyme, 
only 24.8 residues of arginine per subunit were found in 
this sample. Hence, complete inactivation was associated 
with the loss of 1.5 arginine residues per ligase subunit. 
The correlation between the loss of ligase activity and 
the incorporation of [i4C]phenylglyoxal as a function of 
time is shown in Fig. 4. If it is assumed that the stoichi- 
ometry of reaction is as noted earlier, the data again in- 
dicate that approximately two arginine residues/ligase 
subunit are modified in the inactivated enzyme. 
Isolation and purification ofpeptides containingphenyl- 
glyoxal-modified residues. S. aureus V8 endoproteinase 
was used to obtain peptide digests of E. coli 2-amino-3- 
ketobutyrate ligase modified by [ 14C]phenylglyoxal. A 
representative peptide map of a digest separated by HPLC 
is shown in Fig. 5A. Fractions eluted at 11 to 13 min 
contained 88% of the applied radioactivity with the re- 
maining 12% found in fractions at 43 to 46 min. We were 
surprised that when the fractions containing the first ra- 
dioactive peak were chromatographed a second time on 
a Novapak Cis column with a different acetonitrile gra- 
dient (i.e. 28-35s acetonitrile in 0.1% TFA over 0 to 60 
min), the eluted radioactive peak showed no absorptivity 
at 214 nm (data not shown). We therefore took ligase that 
had been inactivated by reaction with [14C]phenylglyoxal 
but was not digested with the endoproteinase and sub- 
jected it directly to HPLC on the Novapak column under 
the same experimental conditions. Again in this instance, 
TIME (mtn) 
FIG. 4. Correlation of the extent of inactivation of E. coli 2-amino- 
3-ketobutyrate ligase activity by phenylglyoxal with the number of mol 
of [‘“C]phenylglyoxal bound to the enzyme. The ligase was inactivated 
by incubating with phenyl[2-i%]glyoxal. At the times indicated, an al- 
iquot (IO ~1) was removed for assaying ligase activity and another (60 
al) for precipitating, washing, and redissolving the protein before mea- 
suring the level of radioactivity present. Experimental details are given 
under Materials and Methods. 
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FIG. 5. Peptide maps of E. coli 2-amino-3-ketobutyrate ligase after 
digestion with Staphylococcus aureus V8 endoproteinase. (A) Ligase in- 
activated approximately 97% by reaction with phenyl[2-“C]glyoxal. (B) 
Rechromatography of the second radioactive peptide eluting at 43 to 46 
min in peptide map (A). The solid histograms indicate the amount of 
radioactivity found in the collected fractions. Experimental details are 
given under Materials and Methods and in the text. 
the major radioactive peak (eluting at 12 to 13 min con- 
taining 80% of applied radioactivity) showed no 214-nm 
absorptivity (data not shown). This result suggests that 
the early-eluting, major radioactive peak seen in Fig. 5A 
is likely due to the presence of free phenylglyoxal which 
is leached from any bound form of the reagent under 
HPLC experimental conditions. The second radioactive 
peak in Fig. 5A (eluting at 43 to 46 min) was therefore 
pooled and rechromatographed on the Novapak C,s col- 
umn using a linear gradient over 60 min of 28-35s ace- 
tonitrile in 0.1% aqueous TFA. As can be seen in Fig. 5B, 
a fairly broad uv-absorbing peak containing most of the 
applied radioactivity was eluted between approximately 
13 and 15 min. These fractions were pooled and the sample 
was subjected to amino acid analysis as well as sequence 
determination. Although the purity of the eluted peak 
was suspect because of its shape, the very clean PTH- 
amino acid chromatograms we obtained throughout the 
manual Edman degradation procedure excluded the pos- 
sibility of this peak being contaminated by other peptides. 
The broadness of the peak is most likely due to slow 
leaching during chromatography of free phenylglyoxal 
from the peptide-dione adduct. 
Amino acid composition and sequence determination of 
the radioactive peptide. The radioactive peptide isolated 
as shown in Fig. 5B was hydrolyzed with 6 N HCl con- 
taining 1% phenol and its composition determined by 
HPLC as PTC-amino acid derivatives using the Waters 
Pica-Tag system. The results are shown in Table I; when 
calculated to the nearest whole integer, a total of 30 amino 
acid residues was found including two arginines. These 
two residues were detected as PTC-arginine rather than 
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TABLE I 
Amino Acid Composition of the [i4C]Phenylglyoxal-Arginine 
Peptide of E. coli Z-Amino-3-ketobutyrate Ligase 
Amino acid” Residue/peptide* 
Glu/Gln 3.90 (4) 
Ser 0.90 (1) 
GUY 2.73 (3) 
His 0.82 (1) 
Arg 2.00 (2) 
Thr 2.40 (2) 
Ala 3.50 (3) 
Pro 2.33 (2) 
TY~ 1.70 (2) 
Val 3.30 (3) 
Met 0.74 (1) 
Ile 2.60 (3) 
Phe 1.76 (2) 
LYS 0.70 (1) 
Total 30 
Residues in enzyme 
















a Determined by HPLC as PTC-amino acid derivatives using the Wa- 
ters Pica-Tag system (24). 
* The first values listed are from amino acid analyses; data are the 
average of duplicate samples hydrolyzed and analyzed separately. The 
nearest whole integer numbers are given in parentheses. 
’ From Aronson et al. (16). 
PTC-phenylglyoxal-arginine peaks since the Pica-Tag 
procedure is carried out under highly alkaline conditions. 
Manually, we were able to determine the sequence of the 
first 17 amino acid residues of this peptide by the thin- 
film and partitioning method of Tarr (25); it had the pri- 
mary structure Gly-Ile-Tyr-Val-Thr-Gly-Phe-Phe- 
Tyr-Pro-Val-Val-Pro-Lys-Gly-Gln-Ala. From the 
known amino acid sequence for E. coli 2-amino-3-keto- 
butyrate ligase, as deduced from DNA sequencing (16), 
and the known specificity of the V8 endoproteinase for 
cleaving peptide bonds involving the carboxyl group of 
glutamic acid, it can be determined that this 17-amino- 
acid sequence corresponds to residues 349 to 365 in the 
primary structure of the ligase. Consequently, the com- 
plete 30-amino-acid peptide as isolated represents the 
stretch from residues 349 to 378 in the intact enzyme. 
The amino acid composition as found for the isolated 
peptide is consistent with this conclusion. 
DISCUSSION 
The primary importance of the threonine dehydroge- 
nase-initiated pathway in threonine metabolism, whereby 
L-threonine is converted by the two-step, sequential action 
of threonine dehydrogenase and 2-amino-3-ketobutyrate 
ligase to 2-amino-3-ketobutyrate and then acetyl CoA 
plus glycine, has come to the forefront in recent years. 
The genes for these two enzymes make up the tdh operon. 
The tdh operon lies within a 3.6-kb EcoRI fragment lo- 
cated at coordinate 81.2 of the E. coli genetic map (11); 
the kbl gene is immediately upstream of the tdh gene 
within the same EcoRI fragment and both genes are tran- 
scribed from a common promoter (6,11,31). The operons 
of a multigene family which includes tdh, collectively 
known as the “leucine regulon,” are up- or down-regulated 
by L-leucine via a leucine-responsive regulatory protein 
encoded by the lrp gene. Lrp transcriptionally regulates 
the operons containing the ilvlH, serA, sdaA, oppABCDF, 
and tdh genes; L-leucine induces the activity of the tdh 
operon about sevenfold. 
One phase of our research is to elucidate the properties 
and structure/function interrelationships of the two gene 
products of the E. coli tdh operon. Past efforts have led 
to the isolation of both proteins in homogeneous form, 
and some of the general properties of each have been de- 
scribed (3, 15). So far, we have succeeded in identifying 
2 catalytically essential amino acid residues in threonine 
dehydrogenase, namely, an arginine (19) and a cysteine 
(18) residue. Other than for identifying lysine 244 as the 
residue that forms the azomethine (Schiff base) linkage 
with pyridoxal 5’-phosphate in 2-amino-3-ketobutyrate 
ligase (20), no other details interrelating structure with 
catalytic capability are known for this enzyme from E. 
coli. The results presented here establish the presence of 
an active-site arginine residue (or two) near the C-ter- 
minus of this ligase. 
While cr-dicarbonyl compounds occasionally react with 
residues in proteins other than arginine (30,32-35), they 
are among the more specific reagents currently available 
for modification of a specific amino acid. E. coli 2-amino- 
3-ketobutyrate ligase is rapidly inactivated by 2,3-bu- 
tanedione and phenylglyoxal; reaction with the less widely 
utilized reagent, 4-(oxyacetyl)phenoxyacetic acid, which 
was uniquely useful for us in other studies with 2-keto- 
4-hydroxyglutarate aldolase (36), also effectively inacti- 
vates this ligase. Appropriate experimental conditions 
and/or controls rule out the possibility that the observed 
loss of ligase activity is due to photo-induced nonspecific 
alteration of the enzyme, ligand-induced dissociation of 
the enzyme into its subunits, or ligand-induced dissocia- 
tion of the coenzyme. Kinetic analyses with the native 
and partially inactivated ligase show that the K, value 
for glycine is essentially unchanged whereas V,,, for the 
modified enzyme is correspondingly lower; such effects 
are consistent with an inactivation process in which active 
and completely inactivated enzyme molecules are present 
(37). These kinetic results together with the good level of 
protection against inactivation observed in the presence 
of substrates and the coenzyme strongly suggest that the 
arginine residue(s) identified here is within the active 
center of the enzyme. 
E. coli 2-amino-3-ketobutyrate ligase contains a total 
of 26 arginine residues/subunit (15,16); of this total, about 
half are present in the amino acid sequence that makes 
up the last f of the protein molecule at the C-terminal 
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end. Comparative amino acid analyses of the native and 
the phenylglyoxal-inactivated enzyme and data correlat- 
ing the loss of ligase activity with the number of moles 
of [‘4C]phenylglyoxal incorporated indicate a stoichi- 
ometry of approximately 2 arginine residues modified/ 
subunit in the completely inactivated enzyme. The ra- 
dioactive peptide isolated by HPLC after protease diges- 
tion contained 2 arginines, namely, residues 366 and 368 
(the C-terminus is alanine-398). Whether both of these 
arginine residues are indeed labeled by reaction with 
[‘4C]phenylglyoxal could not be determined in this study 
and whether both are participants in the active site of 
this enzyme awaits the development of an alternate ex- 
perimental technique. The long length (30 amino acid 
residues) of this peptide precluded manual sequencing of 
it in its entirety, and even if this had been possible the 
results would probably not be definitive since manual Ed- 
man amino acid sequencing techniques involve highly ba- 
sic conditions which regenerate free phenylglyoxal from 
the phenylglyoxal-arginine adduct. Selective changing of 
these 2 arginine residues separately and together by site- 
directed mutagenesis would probably be most informative. 
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